NVCN - ネオバスク (Neovasc Inc.)

NVCNのニュース

   Neovasc Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference  2021/01/04 21:05:00 GlobeNewswire
VANCOUVER and MINNEAPOLIS, Jan. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (Nasdaq, TSX: NVCN), today announced its participation…
   The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Neovasc Inc. (NVCN)  2021/01/04 16:23:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $NVCN #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Neovasc Inc. (NVCN)
   NVCN FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Reminds Neovasc Inc. Investors of Important Tuesday Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NVCN - Stocks News Feed  2021/01/03 21:00:00 Stocks News Feed
NEW YORK, Jan. 03, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. (NASDAQ: NVCN) between October 10, 2018 and October 27, 2020, inclusive (the “Class Period”) of the important January 5, 2021 lead plaintiff deadline in the securities class action. The lawsuit… Read More »NVCN FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Reminds Neovasc Inc. Investors of Important Tuesday Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NVCN
   NVCN Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Neovasc Inc. Investors of Class Action and Lead Plaintiff Deadline: January 5, 2021 | MarketScreener  2021/01/03 16:02:02 MarketScreener
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Neovasc Inc. and certain of its officers, on behalf of shareholders who purchased or… | January 3, 2021
   NVCN Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Neovasc Inc. Investors of Class Action and Lead Plaintiff Deadline: January 5, 2021  2021/01/03 16:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Neovasc Inc. ("Neovasc" or "the Company") (NASDAQ: NVCN) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Neovasc securities between November 1, 2019 and October 27, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/nvcn. This cla
   Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against Neovasc Inc. – NVCN - Stocks News Feed  2020/12/19 14:14:00 Stocks News Feed
NEW YORK, Dec. 19, 2020 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Neovasc Inc. (NASDAQ:NVCN) between November 1, 2019 and October 27, 2020, inclusive (the “Class Period”). To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=neovasc-inc&id=2476 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or… Read More »Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against Neovasc Inc. – NVCN
   EFFECT - NEOVASC INC (0001399708) (Filer) - Stocks News Feed  2020/12/17 05:15:28 Stocks News Feed
Accepted 2020-12-17 00:15:28 Documents Stock Market Shirts | Stock Trading Mugs | Stock Trader Decor | Investing Books 1 Effectiveness Date 2020-12-16 Registration Form F-10 Document Format Files Mailing Address 2135 13700 Mayfield place RICHMOND A1 00000 Business Address 2135 13700 Mayfield place RICHMOND A1 00000 604-270-4344 NEOVASC INC (Filer) CIK: 0001399708 (see all company… Read More »EFFECT – NEOVASC INC (0001399708) (Filer)
   Neovasc Receives Nasdaq Notification Concerning Minimal Bid price Deficiency Nasdaq:NVCN  2020/12/15 02:23:32 Fintech Zoom
Neovasc Receives Nasdaq Notification Concerning Minimal Bid price Deficiency Nasdaq:NVCN -
   ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Neovasc Inc. Investors of Important January 5 Deadline in Securities Class Action - NVCN  2020/12/08 23:59:00 PR Newswire
NEW YORK, Dec. 8, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. (NASDAQ: NVCN) between October 10, 2018 and October 27, 2020, inclusive (the "Class Period") of the important January 5, 2021 lead plaintiff…
   ROSEN, A GLOBALLY RECOGNIZED FIRM, Reminds Neovasc Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NVCN - Stocks News Feed  2020/12/03 22:43:09 Stocks News Feed
NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. (NASDAQ:NVCN) between November 1, 2019 and October 27, 2020, inclusive (the “Class Period”) of the important January 5, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover… Read More »ROSEN, A GLOBALLY RECOGNIZED FIRM, Reminds Neovasc Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NVCN
   Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intercept Pharmaceuticals, Neovasc, Interface, and Biogen and Encourages Investors to Contact the Firm - Stocks News Feed  2020/11/19 02:00:00 Stocks News Feed
NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), Neovasc, Inc. (NASDAQ:NVCN), Interface, Inc. (NASDAQ:TILE), and Biogen, Inc. (NASDAQ:BIIB). Stockholders have until the deadlines below to petition… Read More »Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intercept Pharmaceuticals, Neovasc, Interface, and Biogen and Encourages Investors to Contact the Firm
   NVCN IMMINENT DEADLINE: Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against Neovasc Inc. – NVCN - Stocks News Feed  2020/11/17 16:15:00 Stocks News Feed
NEW YORK, Nov. 17, 2020 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Neovasc Inc. (NASDAQ: NVCN) between November 1, 2019 and October 27, 2020, inclusive (the “Class Period”). To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=neovasc-inc&id=2476 or call Sophie Zhang, Esq. toll-free at 800-991-3756… Read More »NVCN IMMINENT DEADLINE: Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against Neovasc Inc. – NVCN
   SHAREHOLDER DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Neovasc Inc.– NVCN; IMPORTANT DEADLINE-NVCN - Stocks News Feed  2020/11/16 18:46:00 Stocks News Feed
NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Neovasc Inc. (NASDAQ: NVCN) from November 1, 2019 through October 27, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Neovasc Inc. investors under… Read More »SHAREHOLDER DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Neovasc Inc.– NVCN; IMPORTANT DEADLINE-NVCN
   The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations  2020/11/13 12:40:10 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 12) ALX Oncology Holdings Inc (NASDAQ: ALXO ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Denali Therapeutics Inc (NASDAQ: DNLI ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) (announced preclinical data supporting evaluation of FPA157 as a novel immunomodulator with the potential to remove Treg-mediated immune suppression in solid tumors) Generation Bio Co (NASDAQ: GBIO ) Guardant Health Inc (NASDAQ: GH ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Inspire Medical Systems Inc (NYSE: INSP ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD ) (announced presentation of clinical study data on its investigational therapy KSI-301 in retinal disorders) Kura Oncology Inc (NASDAQ: KURA ) MannKind Corporation (NASDAQ: MNKD ) Myokardia Inc (NASDAQ: MYOK ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Oncorus Inc (NASDAQ: ONCR ) OncoSec Medical Inc (NASDAQ: ONCS ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Repligen Corporation (NASDAQ: RGEN ) Shockwave Medical Inc (NASDAQ: SWAV ) Spero Therapeutics Inc (NASDAQ: SPRO ) Tcr2 Therapeutics Inc (NASDAQ: TCRR ) (announced its third-quarter results) Twist Bioscience Corp (NASDAQ: TWST ) Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ) Veracyte Inc (NASDAQ: VCYT ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov.
   Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Neovasc Inc. (NVCN) - Stocks News Feed  2020/11/12 16:30:00 Stocks News Feed
BENSALEM, Pa.–(BUSINESS WIRE)–$NVCN #CLASSACTION–Law Offices of Howard G. Smith reminds investors of the upcoming January 5, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) securities between November 1, 2019 and October 27, 2020, inclusive (the “Class… Read More »Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Neovasc Inc. (NVCN)

calendar